Launch of the Viral Vector Manufacturing Leadership Program

29 Apr 2026

This month we were pleased to launch the Viral Vector Manufacturing Facility (VVMF) Leadership Program, a timely step forward alongside the pioneering work of VVMF. As Australia’s first advanced manufacturer of viral vectors, VVMF sits at the sharp edge of modern medicine, in advanced therapeutics,  where viral vectors play a crucial role in delivering genetic material into cells and are central to innovative treatments in areas of medicine including the treatment of cancers and rare diseases.

VVMF is working in close collaboration with world-renowned scientists, clinicians, and biopharma companies to bring these therapies to life, manufactured to GMP standards, scaled with precision, and driven by a clear mission “Unlocking the future of medicine”

The Leadership Program enters at exactly the right point in VVMF’s story. Translating cutting-edge discovery into real world impact demands leaders who can navigate complexity, make collaborative, well considered decisions under pressure, and hold both ambition and responsibility in the same breath.

To learn more about VVMF click here.

If you would like to learn more about HG’s leadership programs, visit our website here or book a 1:1 consultation with the Executive Director Leadership & Learning here:Meet with Christine Leahy.